The Indian study conducted on 245 metastatic NSCLC patients for concordance of EGFR mutation by ctDNA versus tissue biopsy showed concordance of 82.9 % between plasma and tissue testing, sensitivity and specificity of NGS were 68.4 % and 90.1 %, respectively [24]. Here, EGFR is linked to non-small cell lung carcinoma.